 Opposing Views | FDA Approves Pump for Heart Failure Patients Waiting for Transplant Opposing Views The U.S. Food and Drug Administration today approved the HeartWare Ventricular Assist System, a left ventricular assist device (LVAD), to support heart function and blood flow in patients with end-stage heart failure who are awaiting a heart transplant. FDA Approves Pump for Heart-Failure Patients Awaiting Heart Transplant FDA approves HeartWare Ventricular Assist System to treat end-stage heart failure FDA approves HeartWare pump for heart failure patients awaiting transplant |
